Victory Capital Management Inc. boosted its stake in Humana Inc. (NYSE:HUM) by 3.0% during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 5,987 shares of the insurance provider’s stock after buying an additional 175 shares during the period. Victory Capital Management Inc.’s holdings in Humana were worth $1,077,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in the company. Daiwa SB Investments Ltd. boosted its stake in shares of Humana by 7.5% in the second quarter. Daiwa SB Investments Ltd. now owns 720 shares of the insurance provider’s stock valued at $132,000 after buying an additional 50 shares in the last quarter. Bessemer Group Inc. boosted its stake in shares of Humana by 392.6% in the first quarter. Bessemer Group Inc. now owns 1,000 shares of the insurance provider’s stock valued at $183,000 after buying an additional 797 shares in the last quarter. First Republic Investment Management Inc. boosted its stake in shares of Humana by 1.8% in the first quarter. First Republic Investment Management Inc. now owns 1,145 shares of the insurance provider’s stock valued at $209,000 after buying an additional 20 shares in the last quarter. BB&T Securities LLC boosted its stake in shares of Humana by 13.6% in the second quarter. BB&T Securities LLC now owns 1,374 shares of the insurance provider’s stock valued at $247,000 after buying an additional 165 shares in the last quarter. Finally, Spark Investment Management LLC purchased a new stake in shares of Humana during the first quarter valued at $274,000. 93.24% of the stock is owned by hedge funds and other institutional investors.

Shares of Humana Inc. (NYSE:HUM) traded up 0.22% during midday trading on Thursday, hitting $176.23. The stock had a trading volume of 257,393 shares. The company’s 50 day moving average is $177.35 and its 200 day moving average is $176.67. Humana Inc. has a 52 week low of $150.00 and a 52 week high of $191.65. The firm has a market cap of $26.27 billion, a P/E ratio of 27.07 and a beta of 0.91.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, August 3rd. The insurance provider reported $2.30 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.23 by $0.07. Humana had a return on equity of 11.11% and a net margin of 1.76%. The company earned $14 billion during the quarter, compared to the consensus estimate of $13.59 billion. During the same period last year, the company earned $1.67 earnings per share. The firm’s revenue was up 2.0% compared to the same quarter last year. On average, equities analysts predict that Humana Inc. will post $9.26 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 28th. Stockholders of record on Thursday, October 13th will be given a dividend of $0.29 per share. The ex-dividend date is Tuesday, October 11th. This represents a $1.16 dividend on an annualized basis and a dividend yield of 0.66%. Humana’s dividend payout ratio (DPR) is 18.18%.

Several analysts have weighed in on HUM shares. Zacks Investment Research raised Humana from a “hold” rating to a “buy” rating and set a $197.00 price objective for the company in a report on Monday, July 25th. Jefferies Group restated a “buy” rating and set a $220.00 target price (up from $210.00) on shares of Humana in a research report on Monday, July 25th. RBC Capital Markets restated a “buy” rating and set a $224.00 target price (up from $220.00) on shares of Humana in a research report on Friday, July 22nd. Cantor Fitzgerald restated a “buy” rating on shares of Humana in a research report on Saturday, July 9th. Finally, Barclays PLC decreased their target price on Humana from $193.00 to $191.00 and set an “equal weight” rating for the company in a research report on Thursday, August 4th. Six investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The stock has a consensus rating of “Buy” and an average target price of $201.00.

About Humana

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

5 Day Chart for NYSE:HUM

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM).

Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.